Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
113.79
-0.09 (-0.08%)
At close: Feb 27, 2026, 4:00 PM EST
113.77
-0.02 (-0.02%)
After-hours: Feb 27, 2026, 4:53 PM EST
Arcellx Market Cap
Arcellx has a market cap or net worth of $6.65 billion as of February 27, 2026. Its market cap has increased by 94.31% in one year.
Market Cap
6.65B
Enterprise Value
6.18B
1-Year Change
94.31%
Ranking
Category
Stock Price
$113.79
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $6.65B, an increase of 1,222.19%. That is a compound annual growth rate of 88.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 6.65B | 76.46% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvalent | 7.92B |
| Cytokinetics | 7.61B |
| Kymera Therapeutics | 7.43B |
| Belite Bio | 7.14B |
| Cogent Biosciences | 6.26B |
| Rhythm Pharmaceuticals | 6.23B |
| Protagonist Therapeutics | 5.88B |
| CRISPR Therapeutics AG | 5.77B |